Tenderwize
Wróć do wyszukiwania

Medicinal product with olodaterol and tiotropium bromide (ATC: R03AL06)

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline Apr 29, 2027 · 249 days left·Open·Supplies
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Olodaterol und Tiotropiumbromid (ATC: R03AL06)

50/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

50 / 100

Złożoność

20 / 100

Czynniki ryzyka

No estimated contract value or budget is disclosed, so potential revenue cannot be assessed.

If the authority awards exclusive contracts during the term, the open-house contracts will be terminated.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Non-exclusive discount agreements for finished medicinal products containing olodaterol and tiotropium bromide (ATC: R03AL06)
  • Open-house model: any qualified pharmaceutical company can join at any time
Pokaż pełne podsumowanie

This is an open-house model for non-exclusive discount agreements under § 130a Abs. 8 SGB V for finished medicinal products containing the active substances olodaterol and tiotropium bromide (ATC: R03AL06). The contracting authority is AOK Sachsen-Anhalt. Any qualified pharmaceutical company can join at any time under standard terms. The contract runs from 1 July 2025 to 30 June 2027 (max 24 months). There is no estimated value provided. The procedure is not a public procurement under EU law despite using an open procedure notice form. Submission is via postal mail or electronically with qualified electronic signature. The deadline for submission is 30 April 2027, but the model allows participation at any time until that date.

Ryzyka

No estimated contract value or budget is disclosed, so potential revenue cannot be assessed.

If the authority awards exclusive contracts during the term, the open-house contracts will be terminated.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Must be a pharmaceutical company or a group of pharmaceutical companies

Administrative

  • Complete and sign the participation documents
  • Submit participation documents via postal mail or electronically with qualified electronic signature

Kryteria udzielenia

Lot 1

No award criteria defined; open to all qualifying companies.

Zamawiający

Lokalizacja

Magdeburg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE258393558

Działalność

Health

Części (1)

LOT-0001

Medicinal product with olodaterol and tiotropium bromide (ATC: R03AL06)

Non-exclusive discount agreements for finished medicinal products containing olodaterol and tiotropium bromide (ATC: R03AL06) under an open-house model. Any eligible pharmaceutical company can conclude a contract at any time. Contract duration maximum 24 months ending 30 June 2027. The contract may be terminated if the authority awards exclusive contracts later.

SuppliesEU fundedElectronic submission

Lokalizacja

DEE03, Germany

Czas trwania

2 YEAR

Kategoria

Pharmaceutical products

Kryteria udzielenia

No award criteria defined; open to all qualifying companies.

Termin

Deadline Apr 29, 2027

Szczegóły zamówienia

Data publikacji
18 May 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
320165-2025

Dokumenty (1)

Podobne przetargi